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Dermatological disorders related to pigmentation result in tenuous hyper or hypopigmentation 
Cosmetic and pharmaceutical products containing depigmenting substances are used in the treatment 
of patients who have high pigmentation disorders, such as melasma or chloasma, post-inflammatory 
hyperpigmentation, senile lentigo and ephelides. Skin lightening agents are not yet totally effective or 
safe and therefore intensive research for the discovery of new agents is continuous. Enzyme inhibitors 
involved in melanogenesis, such as tyrosinase, have been discovered in Asian countries, including those 
isolated from plant extracts. The Brazilian flora has the highest species diversity in the world, and the 
chemical, pharmacological and cosmetic potential for the discovery of new skin whitening agents is in 
proportion with this biodiversity. For these reasons, 25 aqueous and 24 organic extracts obtained from 
19 plants native to the Amazon rain forest and to the Atlantic forest, belonging to 11 different families, 
were evaluated as tyrosinase inhibitors. Nine out of 49 extracts showed inhibitory activity in the screening 
process. The 50% inhibitory activity (IA
50
) was calculated, revealing that the most active extracts were 
the organic extracts from the leaves and stem of Ruprechtia sp. (IA
50
 33.76 mg.mL-1) and the organic 
extract from the aerial organs of Rapanea parviflora (IA
50
 64.19 mg.mL-1).
Uniterms: Tyrosinase. Melanin. Plant extract/in vitro evaluation. Skin lightening agents. Amazonian 
plants/evaluation/dermatological use.
Problemas dermatológicos relacionados com a pigmentação resultam em hiperpigmentações ou 
hipopigmentação cutâneas. Produtos cosméticos e farmacêuticos com atividade despigmentante são 
utilizados para o tratamento de pacientes que apresentam distúrbios de hiperpigmentação, tais como 
melasma ou cloasma, hiperpigmentação pós-inflamatória, lentigem senil e efélides. Os despigmentantes 
atualmente utilizados não são totalmente eficazes ou seguros, razão pela qual há intensa pesquisa, 
principalmente em países asiáticos, com a finalidade de se obter novos agentes com esta ação, em especial 
inibidores de enzimas envolvidas na melanogênese, como a tirosinase. Considerando-se que algumas 
substâncias obtidas de plantas apresentam essa atividade, a flora brasileira constitui-se uma fonte potencial 
de obtenção de novos despigmentantes. Por essa razão, 25 extratos aquosos e 24 orgânicos obtidos de 19 
plantas da Floresta Amazônica e Mata Atlântica, provenientes de 11 diferentes famílias, foram avaliados 
quanto à atividade de inibição da tirosinase. Do total de 49 extratos testados, 9 mostraram atividade. Os 
valores de concentração da atividade inibitória 50% (AI 50%), foram calculados e o mais ativo foi o 
extrato orgânico das folhas e caule de Ruprechtia sp. (AI
50
 33,76 mg.mL-1) seguido do extrato orgânico 
dos órgãos aéreos de Rapanea parviflora (AI
50
 64,19 mg.mL-1).
Unitermos: Tirosinase. Melanina. Extrato de plantas/avaliação in vitro. Despigmentantes. Plantas 
amazônicas/avaliação/uso dermatológico. 
INTRODUCTION
For centuries, humans have tried to artificially 
modify the color of their skin, both by using whitening 
or darkening products. Such attitudes were related to phi-
losophy, beliefs, religion and mainly to vanity (Shevlin, 
1974). Over-exposure of the skin to ultraviolet light is 
related to human ostentation, but it can also be related to 
pigmenting problems or even to skin cancer (Podahaisky 
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et al., 2002). As the world population ages it becomes 
even more important to treat pigment disorders (Benech, 
2002). Severe anomalies may also hamper an individual 
in social relationships (Grimes, 1999). 
Both hyper and hypopigmentation are treated 
with cosmetic or pharmaceutical products containing 
depigmenting substances, which are synthetic or of na-
tural origin. Pigmentation disorders can also be treated 
with mechanical peeling allied to chemical substances 
or treatments with laser rays (Grimes, 1999).
The skin produces a complex mixture of enzymes 
for protection from the constant exposition to environ-
mental oxidative stress (Podahaisky et al., 2002), but in 
some situations this is insufficient to prevent disorders 
from appearing. However, the fact that drugs can be 
absorbed by the skin (Thorsteinsson et al., 1999) aids 
in the development of cosmetic preparations to treat 
skin pigmentation or depigmentation, particularly drugs 
whose active substance is a natural product.
One of the most effective depigmenting substan-
ces is hydroquinone, which inhibits the synthesis of 
melanin. Enzyme inhibition is one of the mechanisms 
involved in melanogenesis (Lee, Choi, 1998).
Many screening studies are reported in the li-
terature, with emphasis on those products made with 
tyrosinase inhibitors from African plants (Baurin et 
al., 2002; Kubo, Hori, 1999b, Momtaz et al., 2008), 
Bolivia (Kubo et al., 1995), China (Iida et al., 1995; 
Masamoto et al., 1980; Miao et al., 1997), Japan (No 
et al., 1999), Bangladesh (Khanom et al., 2000) and 
others. Positive results in relation to activity were obtai-
ned and some authors continued this work by isolating 
active substances.
Considering that current therapies have shown less 
than satisfactory results in the treatment of various derma-
tological disorders such as melasma, post-inflammatory 
or senile lentigo and ephelides, and that the side effects of 
the therapy include high cytotoxicity and mutagenicity, 
poor skin penetration and low stability of formulations 
(Grimes, 1999; Nerva et al., 2003), new drugs with enzy-
me inhibitory activity are needed(Su, 1999). 
Satisfactory results obtained from screening stu-
dies previously conducted by other groups, reporting 
the identification of inhibitory activity of melanoge-
nesis by plant extracts, allied with the fact that Bra-
zilian biodiversity corresponds to 20% of the world’s 
biodiversity (Suffredini et al., 2004) justify the current 
project of screening Brazilian plant extracts such as 
tyrosinase inhibitors in vitro, so that agents may be 
found and eventually used in cosmetic and pharma-
ceutical products. 
MATERIAL AND METHODS
Plant extracts
The plant material listed in Table I was collected 
from igapó, terra firme and Atlantic forests, according 
to a chemosystematic approach. Vouchers were depo-
sited in the Herbarium UNIP, where they were identi-
fied. After collection, the material was ground up and 
24h-macerated with a mixture of dichloromethane and 
methanol (1:1), followed by 24h-maceration with Milli-
Q water. The organic extracts were evaporated under 
reduced pressure (Büchi) and the aqueous extracts were 
lyophilized (Virtis). All the extracts were stored in a 
freezer (-27 ºC, Revco) until use (Younes et al., 2000).
Tyrosinase enzymatic reaction assay
The assay was realized with modifications (Kha-
nom, 2000; Kobayashi et al., 1995), such that 10 mL of 
the solution made with 120 U.mL-1 (1st screening) or 
480 U.mL-1 (2nd screening) of tyrosinase obtained from 
mushrooms (Sigma) were added to 96-well micropla-
tes, as were 70mL of pH 6.8 buffer solution and 60 mL 
of the plant extract solutions (water or DMSO 50% in 
water, were used as vehicles). A negative control was 
used, as was a positive control made with a solution of 
kojic acid. To this mixture, 70 mL of L-tyrosine (Sigma) 
were added, completing the final volume up to 210 mL. 
The absorbance was taken at 490nm in a microplate 
spectrophotometer reader (Biotek) in the beginning 
of the reaction, as the time zero reading. Microplates 
were incubated at (30±1) ºC for 120 minutes in the first 
screening, and for 60 minutes in the second screening. 
Optical densities were registered on a computer coupled 
to the spectrophotometer reader. Inhibitory activity of 
50% was obtained according to the formula
IA (%) = [((C-T
0
)-(S- T
0
))/(C- T
0
)] x 100
where IA = inhibitory activity, C= control absorbance 
at 490 nm, S= test absorbance at 490 nm and T
0
= time 
zero, and each parameter was a mean of 8 measures.
The percentage of inhibitory activity of tyrosi-
nase obtained from the extracts was compared to that 
obtained from the kojic acid.
Tyrosinase inhibitory activity by plant extracts
The first screening was performed as previously 
described, using tyrosinase at 120 U.mL-1. The final 
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concentration in the assay was 80 mg/mL (mg.ml-1) 
for the extracts, and 5 mg.mL-1 for kojic acid, used as 
a positive control. Readings were taken 120 minutes 
after the addition of the extract or kojic acid. The active 
extracts were submitted to a second screening, whose 
enzyme concentration was 480 U.mL-1.
Determination of the inhibitory activity at 50%, 
of kojic acid using tyrosinase at concentrations 
of 120 U.mL-1 and 480 U.mL-1
The test was performed as first described. Tyro-
sinase was diluted to 120 U.mL-1 and 480 U.mL-1, in 
the first and second screening, respectively. Kojic acid 
concentrations used in the test were 5.0, 4.0, 3.0, 2.5, 
1.25, 0.625 and 0.3125 mg.mL-1 in the first screening, 
and 10.0, 5.0, 2.5, 1.25 and 0.625 mg.mL-1 in the second 
screening. 
Determination of the inhibitory activity at 50%, 
of the active extracts
The test was executed as first described, substitu-
ting the kojic acid by plant extracts, whose concentra-
tions were 80.0, 40.0, 20.0 and 10.0 mg.mL-1. 
TABLE I - List of Amazonian Rain Forest plant extracts tested against tyrosinase
Extract* Species Family Plant organ Collection number
01/O
Calophyllum brasiliense Cambess Clusiaceae Stem PS187
02/A
03/O
Ruprechtia sp. Polygonaceae Leaves and Stem PS387
04/A
05/O
Mabea nitida Spruce ex Benth Euphorbiaceae Leaves and Stem PS81
06/A
07/O
Piranhea trifoliata Baill. Euphorbiaceae Leaves PS88 
08/A
09/A Aparisthmium cordatum (A. Juss) Baill. Euphorbiaceae Aerial organs PS393
10/O 
11/A
Piranhea trifoliata Baill. Euphorbiaceae Fruits PS88
12/O
Calophyllum brasiliense Cambess Clusiaceae Fruits PS187
13/A
14/O
Mabea nitida Spruce ex Benth. Euphorbiaceae Fruits PS81
15/A
16/O 
17/A
Malouetia tamaquarina (Aubl.) A. DC. Apocynaceae Aerial organs IBS10
18/O
Calophyllum brasiliense Cambess Clusiaceae Leaves PS187
19/A
20/O
Duguetia uniflora (DC.) Mart. Annonaceae Stem bark PS357
21/A
22/O
Guatteria riparia R. E. Fr. Annonaceae Stem PS115
23/A
24/O 
25/A
Crudia amazonica Spruce ex Benth.
Leguminosae 
Caesalpinioidae
Stem PS90
26/A Guatteria riparia R. E. Fr. Annonaceae Leaves PS115
27/O
Couma utilis (Mart.) Mill. Arg. Apocynaceae Leaves AAO3336
28/A
29/O 
30/A
Macrolobium acaciifolium (Benth.) Benth.
Leguminosae 
Caesalpinoidae
Fruits PS137
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RESULTS AND DISCUSSION
IA
50
 of the kojic acid obtained from the reaction 
with tyrosinase at 120 U.mL-1, calculated from the re-
gression line formula generated after 120 minutes of 
reaction, was 2.99 mg.mL-1. The IA
50
 of the kojic acid, 
obtained from regression line formula generated from the 
reaction with tyrosinase at 480 U.mL-1 after 60 minutes 
was 6.85 mg.mL-1.
Results obtained in the first screening of plant 
extracts as inhibitors of tyrosinase are shown in Table II 
(statistical analysis, T test). The IA
50
 concentrations are 
shown in Table III. 
Skin clarity is an important characteristic, as hyper 
and hypopigmentation affect the self-esteem of an indivi-
dual, but fortunately can be treated, or at least minimized. 
In the last few years the number of whitening products 
on the market has increased dramatically, but therapies 
have not always shown satisfactory results (Su, 1999; 
Tengamnuay et al., 2006), This is principally due to the 
high toxicity of the whitening substances, such as that 
observed for hydroquinone (Grimes, 1999). The present 
observations highlight the need for intensive research 
on new depigmenting substances. The identification of 
enzyme inhibitors involved in melanogenesis, such as 
hydroquinone and kojic acid, is especially important.
Given that plants may contain enzyme inhibitory 
substances, screening methodologies show greater efficacy 
in the identification of active substances (Lee et al., 1999), 
and there are calls to search for active compounds from 
Brazilian plants, the present screening was delineated in 
order to evaluate plant extracts obtained from plants che-
mosystematically related to groups whose phenolic com-
pound production is significant (Iida et al., 1995; Kubo, 
Hori, 1999a; Kubo, 1995; No, 1999). Plants belonging to 
the families: Annonaceae, Apocynaceae, Clusiaceae, Dil-
leniaceae, Euphorbiaceae, Flacourtiaceae, Leguminosae, 
Myrsinaceae, Passifloraceae, Polygonaceae and Rubiaceae 
were assayed. Some plants of these families have already 
been evaluated and have been shown to contain phenolic 
tyrosine inhibitor compounds such as flavonoids and tan-
nins (Iida et al., 1995; Khanom et al., 2000).
The tyrosinase inhibitory effect of 49 aqueous 
and organic extracts obtained from 19 Brazilian plants 
belonging to 11 families was evaluated using a spectro-
photometric method. Kojic acid was chosen as a positive 
control because the substance is an effective inhibitor of 
tyrosinase in vitro (Sandoval, 1999).
Extract* Species Family Plant organ Collection number
31/O
Hevea microphylla Ule Euphorbiaceae Stem PS196
32/A
33/O 
34/A
Taralea oppositifolia Aubl.
Leguminosae 
Faboidae
Leaves PS108
35/O 
36/A
Taralea oppositifolia Aubl.
Leguminosae 
Faboidae
Fruits PS108
37/O
Piranhea trifoliata Baill. Euphorbiaceae Stem PS88
38/A
39/O
Triplaris surinamensis Cham. Polygonaceae Stem AAO3294
40/A
41/O
Davilla rugosa Poir. Dilleniaceae Aerial organs AAO3457
42/A
43/O
Passiflora sp. Passifloraceae Aerial organs AAO3421
44/A
45/O
Rapanea parviflora Aubl. ** Myrsinaceae Aerial organs AAO3458
46/A
47/O
Palicourea grandifolia (A. DC) Mez Rubiaceae Aerial organs AAO3542
48/A
49/O Casearia javitensis Kunth Flacourtiaceae Aerial organs AAO4067
*O = organic extract; A = aqueous extract; ** = Atlantic Forest
TABLE I - List of Amazonian Rain Forest plant extracts tested against tyrosinase (cont.)
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The concentration of tyrosinase used in the first scre-
ening was 120 U.mL-1 in order to increase the sensitivity 
and chances of finding active extracts. As the chemical 
composition of such extracts is not known, further studies 
were needed in order to verify the presence of tyrosinase 
inhibitor substances isolated by bioguided fractionation, 
and will be discussed below. 
Calculations of the extracts’ inhibitory activity on 
melanogenesis were based on the comparison between 
data obtained from tests with extracts, and from negative 
controls. The extracts that showed significant inhibitory 
activity in the 120 minute screening obtained from the 
first screening (03/0, 07/0, 45/0, 11/A, 50/A, 21/A, 32/A, 
34/A and 45/A), and the kojic acid, were submitted to a 
second screening in order to determine the inhibitory ac-
tivity (IA%) and IA
50
, using a concentration of tyrosinase 
of 480 U.mL-1. 
As shown in Table III, all the extracts except 34/A, 
demonstrated positive inhibitory activities. Nonetheless, 
the linearity of the curves obtained to calculate IA
50
 were 
not always significant (R2> 0.90), as was the case with 
extracts 45/O, 15/A and 21/A.
The relative comparison of test and control IA
50
 
showed that IA
50
 obtained for kojic acid was 6.85mg.
mL-1 and that the extract 03/O (Ruprechtia sp. - stem and 
leaves - Polygonaceae, IA
50
 33.76mg.mL-1) was the most 
potent enzyme inhibitor. Nonetheless, the dose dependent 
relationship was not as significant (R2=0.803) as that 
obtained for extract 45/O (Rapanea parviflora - aerial or-
gans - Myrsinaceae, IA
50
 64.19 mg.mL-1, R2=0.9935). Both 
extracts can be considered potential anti-tyrosinase agents 
based on the IA
50
 and R2 values found in the present study 
and on comparison with the values obtained by Khanom 
et al. (2000), where kojic acid yielded IA
50
 = 7.5 mg.mL-1, 
TABLE III - Tyrosinase inhibitory activity of plant extracts.
Extract
IA %*
Equation R2 IA
50
*
10 20 40 80
03/O 28.99 52.61 68.22 82.73 y = 0.9282x + 18.664 0.8032 33.76
07/O 5.50 4.40 5.40 14.23 y = 0.1529x + 1.3198 0.8748 318.37
45/O 10.91 14.85 34.02 61.00 y = 0.7559x + 1.4798 0.9935 64.19
11/A 11.31 10.54 11.16 7.97 y = 0.0446x + 6.8585 0.0872 nd
15/A 6.70 5.80 8.70 16.21 y = 0.1764x + 2.1911 0.9077 271.03
21/A 2.74 8.95 20.23 33.67 y = 0.4354x + 0.0568 0.9845 114.70
32/A 0.71 2.87 3.55 2.31 y = 0.0027x + 1.0773 0.3298 nd
34/A -0.90 -1.32 -0.81 -1.61 y = - 0.0144x – 0.4975 0.5511 nd
44/A 1.93 3.31 2.06 -1.32 y = 0.0293x + 2.0743 0.2537 nd
IA (%) = percentage of inhibitory activity; R2 = coefficient of linear correlation; 
IA
50
 = inhibitory activity at 50%; nd = not determined; *= mg.mL
TABLE II - Tyrosinase reaction in the presence of plant extracts at different concentrations after 60 minutes of exposure
Extract
Extract concentration mg.mL-1
Control** 10 20 40 80
Abs SD Abs SD p Abs SD p Abs SD p Abs SD p
03/O 0.5299 0.0139 0.3763 0.0123 <0.0001* 0.2511 0.0142 <0.0001* 0.1684 0.0249 <0.0001* 0.0915 0.0146 <0.0001*
07/O 0.5299 0.0139 0.5008 0.0086 0.0002* 0.5064 0.0268 0.0450* 0.5013 0.0699 0.2754 0.4545 0.0331 <0.0001*
45/O 0.5430 0.0131 0.4838 0.0539 0.0092* 0.4624 0.0211 <0.0001* 0.3583 0.0136 <0.0001* 0.2118 0.0093 <0.0001*
11/A 0.5005 0.0516 0.4439 0.0064 0.0082* 0.4478 0.0128 0.0141* 0.4446 0.0056 0.0087* 0.4606 0.0164 0.0559
15/A 0.5005 0.0516 0.4668 0.0205 0.1081 0.4714 0.0383 0.2211 0.4568 0.0223 0.0452* 0.4194 0.0086 0.0006*
21/A 0.5840 0.0156 0.5680 0.0064 0.0178* 0.5318 0.0095 <0.0001* 0.4659 0.0117 <0.0001* 0.3874 0.0211 <0.0001*
32/A 0.5840 0.0156 0.5799 0.0122 0.5675 0.5673 0.0080 0.0175* 0.5631 0.0236 0.0554 0.5711 0.0337 0.3425
34/A 0.5583 0.0086 0.5633 0.0216 0.5527 0.5656 0.0161 0.2770 0.5628 0.0227 0.6082 0.5673 0.0199 0.2599
44/A 0.5583 0.0086 0.5475 0.0263 0.2882 0.5394 0.0205 0.0306* 0.5468 0.0251 0.2404 0.5660 0.0117 0.1559
p = values for test T; *=significant; Abs = mean absorbance (n=8); SD = Standard deviation; ** = negative control (without extract).
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and the extract obtained from Glycyrrhyza glabra had 
IA
50
 = 21.2 mg.mL-1.
CONCLUSIONS
The extracts obtained from the leaves and stem of 
Ruprechtia sp. and from the aerial organs of Rapanea 
parviflora were considered the most active in the present 
assay. Extracts obtained from the leaves of Piranhea tri-
foliata, fruits of P. trifoliata, fruits of Mabea nitida, stem 
bark of Duguetia uniflora, stem of Hevea microphylla, 
leaves of Taralea oppositifolia and the aerial organs of 
Passiflora sp. were found to exhibit anti-tyrosinase acti-
vity. These may be interesting candidates for evaluation 
in more complex biological system assays such as toxicity 
in vitro, melanocyte cultures and eventually in human in 
vivo assays.
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